AURIGENE ONCOLOGY LIMITED
OVERVIEW - AURIGENE ONCOLOGY LIMITED
Aurigene Oncology Limited is an unlisted public company incorporated on 10 August, 2001. It is classified as a public limited company and is located in Bangalore, Karnataka. It's authorized share capital is INR 140.00 cr and the total paid-up capital is INR 90.54 cr.
Aurigene Oncology Limited's operating revenues range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by -51.84 % over the previous year. At the same time, it's book networth has decreased by -10.71 %. Other performance and liquidity ratios are available here.
Description: The company is integrated drug discovery company focused on small molecule and peptide drug discovery and development from target identification and validation to pre-IND drug candidates in oncology and inflammation.
Products & Services: Screening, discovery, and rational development of small molecule and peptide drug candidates with cellular mechanisms of action.
Category: Manufacturer
The current status of Aurigene Oncology Limited is - Active.
The last reported AGM (Annual General Meeting) of Aurigene Oncology Limited, per our records, was held on 18 July, 2023.
Aurigene Oncology Limited has eight directors - Venkateswara Prasad Gunupati, Satish Reddy Kallam, and others.
The Corporate Identification Number (CIN) of Aurigene Oncology Limited is U24239KA2001PLC029391. The registered office of Aurigene Oncology Limited is at 39/49(P)KIADB INDUSTRIAL AREA, ELECTRONICS CITY PHASE II, BANGALORE, Karnataka.
REGISTERED DETAILS - AURIGENE ONCOLOGY LIMITED
CIN
U24239KA2001PLC029391
Incorporation Date / Age
10 August, 2001 / 23 yrs
Last Reported AGM Date
18 July, 2023
Authorized Capital
INR 14000.0 Lacs
Paidup Capital
INR 9054.0 Lacs
industry*
Manufacturing (Chemicals and chemical products)
type
Unlisted Public Company
category
Company limited by Shares
subcategory
Non-govt company
Registered Address
39/49(P)KIADB INDUSTRIAL AREA
ELECTRONICS CITY PHASE II
BANGALORE - 560100
Karnataka - India
FINANCIAL HIGHLIGHTS - AURIGENE ONCOLOGY LIMITED
| Operating Revenue | INR 100 cr - 500 cr |
| EBITDA | -51.84 % |
| Networth | -10.71 % |
| Debt/Equity Ratio | 0.00 |
| Return on Equity | 11.22 % |
* Company has reported to have approved financials for 31 March, 2023. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.
Directors - AURIGENE ONCOLOGY LIMITED
The company has 8 directors and 3 reported key management personnel.
The longest serving directors currently on board are Venkateswara Prasad Gunupati and Satish Reddy Kallam who were appointed on 10 August, 2001. They have been on the board for more than 22 years. The most recently appointed director is Venkata Ramana Motupalli, who was appointed on 19 October, 2023.
Satish Reddy Kallam has the largest number of other directorships with a seat at a total of 28 companies. In total, the company is connected to 45 other companies through its directors.
| NAME | DESIGNATION | APPOINTMENT DATE | |
|---|---|---|---|
| VENKATESWARA PRASAD GUNUPATI | Director | 10 August, 2001 | View other directorships |
| SATISH REDDY KALLAM | Director | 10 August, 2001 | View other directorships |
| BUGGANA HARIHARNATH | Director | 30 March, 2015 | View other directorships |
| BRUCE LEONARD ANDREWS CARTER | Director | 30 March, 2015 | No other directorships |
| PARAG AGARWAL | Director | 01 December, 2021 | View other directorships |
| VENKATA RAMANA MOTUPALLI | Director | 19 October, 2023 | View other directorships |
| SHUBHADA VIVEK CHIPLUNKAR | Director | 01 October, 2022 | No other directorships |
| . KUMAR SRINIVASAN | Director | 01 October, 2022 | No other directorships |
| VARUN KUMAR CHALLAPALLI | KMP | 24 January, 2024 | No other directorships |
| Muralidhara Ramachandra | KMP | 01 July, 2019 | No other directorships |
| Brijesh Kumar Karnani | KMP | 26 March, 2020 | No other directorships |
Previous Names
| AURIGENE DISCOVERY TECHNOLOGIES LIMITED |
Previous CINs
| No previous CINs were found for this company. |
SIMILAR COMPANIES
| NAME | INCORPORATION YEAR | STATE | PAID UP CAPITAL | |
|---|---|---|---|---|
|
GAMA COLOURS LIMITED
It was formed in year 1988 in Gujarat . The company currently has a paid up capital of INR 91.00 cr.
|
1988 | Gujarat | 91.00 cr | Buy financial reports |
|
INNOXEL LIFESCIENCES PRIVATE LIMITED
It was formed in year 2020 in Gujarat . The company currently has a paid up capital of INR 90.01 cr.
|
2020 | Gujarat | 90.01 cr | Buy financial reports |
|
DASAMI LAB PRIVATE LIMITED
It was formed in year 2015 in Telangana . The company currently has a paid up capital of INR 90.00 cr.
|
2015 | Telangana | 90.00 cr | Buy financial reports |
|
HIL (INDIA) LIMITED
It was formed in year 1954 in Delhi . The company currently has a paid up capital of INR 91.33 cr.
|
1954 | Delhi | 91.33 cr | Buy financial reports |
|
STHREE CHEMICALS PRIVATE LIMITED
It was formed in year 2020 in Tamil Nadu . The company currently has a paid up capital of INR 89.56 cr.
|
2020 | Tamil Nadu | 89.56 cr | Buy financial reports |
|
USV PRIVATE LIMITED
It was formed in year 1961 in Maharashtra . The company currently has a paid up capital of INR 91.59 cr.
|
1961 | Maharashtra | 91.59 cr | Buy financial reports |
|
INDRAPRASTHA MEDICAL CORPORATION LIMITED
It was formed in year 1988 in Delhi . The company currently has a paid up capital of INR 91.67 cr.
|
1988 | Delhi | 91.67 cr | Buy financial reports |
|
STRIDES PHARMA SCIENCE LIMITED
It was formed in year 1990 in Maharashtra . The company currently has a paid up capital of INR 91.90 cr.
|
1990 | Maharashtra | 91.90 cr | Buy financial reports |
|
INDUS GENE EXPRESSIONS LIMITED
It was formed in year 2007 in Andhra Pradesh . The company currently has a paid up capital of INR 92.83 cr.
|
2007 | Andhra Pradesh | 92.83 cr | Buy financial reports |
|
TAKASAGO INTERNATIONAL INDIA PRIVATE LIMITED
It was formed in year 2000 in Tamil Nadu . The company currently has a paid up capital of INR 87.60 cr.
|
2000 | Tamil Nadu | 87.60 cr | Buy financial reports |
SUBSIDIARY COMPANIES
No Indian subsidiary companies found.
Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to their respective owners. Read More